These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6534309)

  • 1. [Biliary excretion of tenoxicam in cholecystectomized patients].
    Tamimura H; Mukaihara S; Mine Y; Yotsumoto F; Setoyama M; Suzuki T; Kuruma I
    Nihon Geka Hokan; 1984 Nov; 53(6):779-85. PubMed ID: 6534309
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of tenoxicam in rats.
    Ichihara S; Tsuyuki Y; Tomisawa H; Fukazawa H; Nakayama N; Tateishi M; Joly R
    Xenobiotica; 1984 Sep; 14(9):727-39. PubMed ID: 6516446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of tenoxicam on glibornuride kinetics and response.
    Stoeckel K; Trueb V; Dubach UC; Heintz RC; Ascalone V; Forgo I; Hennes U
    Br J Clin Pharmacol; 1985 Feb; 19(2):249-54. PubMed ID: 3157397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of isoxicam: a new nonsteroidal anti-inflammatory drug.
    Downie WW
    Singapore Med J; 1985 Feb; 26(1):29-33. PubMed ID: 3895443
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma and synovial fluid concentrations of isoxicam in meniscectomized patients.
    Ballerini R; Casini A; Chinol M; Mannucci C; Melani F; Ungar F
    Drugs Exp Clin Res; 1985; 11(8):517-21. PubMed ID: 3841790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tenoxicam in patients with impaired renal function.
    Horber FF; Guentert TW; Weidekamm E; Heizmann P; Descoeudres C; Frey FJ
    Eur J Clin Pharmacol; 1986; 29(6):697-701. PubMed ID: 3709612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of tenoxicam for the treatment of rheumatoid arthritis].
    Torisu T; Nobenaga T; Kwasaki Y
    Ryumachi; 1984 Aug; 24(4):295-308. PubMed ID: 6393367
    [No Abstract]   [Full Text] [Related]  

  • 8. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA; Allen JG; Dixon JS; Wright V
    Br J Rheumatol; 1985 Nov; 24(4):351-6. PubMed ID: 3877538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenoxicam in soft-tissue rheumatism.
    Schorn D
    S Afr Med J; 1986 Mar; 69(5):301-3. PubMed ID: 3515589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Piroxicam (Felden)].
    Rugstad HE
    Tidsskr Nor Laegeforen; 1983 Sep; 103(25):1762-3. PubMed ID: 6648913
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of piroxicam by laboratory animals.
    Hobbs DC; Twomey TM
    Drug Metab Dispos; 1981; 9(2):114-8. PubMed ID: 6113108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tenoxicam, a new anti-inflammatory drug, on in vitro neutrophil activation.
    Laghi Pasini F; Capecchi PL; Ceccatelli L; Orrico A; Pasqui AL; Di Perri T
    Boll Chim Farm; 1985 Nov; 124(11):477-82. PubMed ID: 3833264
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic factors as causes of variability in response to non-steroidal anti-inflammatory drugs.
    Brune K
    Agents Actions Suppl; 1985; 17():59-63. PubMed ID: 3879100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory changes produced by piroxicam in rheumatoid arthritis.
    De Zubiria RC; Charria A; Lobo Guerrero D
    Eur J Rheumatol Inflamm; 1983; 6(1):56-62. PubMed ID: 6861814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical study in postoperative bile excretion of cefuzonam].
    Hirano M; Fujimura M; Yamamoto A; Yamamoto I; Nishimura K; Takahara H; Hirano T; Mori A
    Jpn J Antibiot; 1991 Jan; 44(1):9-13. PubMed ID: 2041151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of impairment of renal function on the accumulation and disposition of isoxicam.
    Bury RW; Whitworth JA; Saines D; Kincaid-Smith P; Moulds RF
    Eur J Clin Pharmacol; 1985; 28(5):585-8. PubMed ID: 4043201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of piroxicam in man.
    Hobbs DC
    Eur J Rheumatol Inflamm; 1983; 6(1):46-55. PubMed ID: 6861813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoxicam.
    Downie WW; Gluckman MI; Ziehmer BA; Boyle JA
    Clin Rheum Dis; 1984 Aug; 10(2):385-99. PubMed ID: 6391795
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of activated charcoal on the bioavailability of piroxicam in man.
    Laufen H; Leitold M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipyretic effect of tenoxicam and paracetamol in febrile children.
    Similä S; Kylmämaa T
    Drugs Exp Clin Res; 1985; 11(10):731-4. PubMed ID: 3915461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.